was 77%, during which four patients died of nonaortic disease. Reintervention rate at 2 years was 24% (Fig). One patient had an open conversion for type IA endoleak, one patient has had continued aneurysmal growth during 6 years by non-contrast-enhanced imaging but has declined intervention, and one patient has a type IB leak but elected to complete a course of chemotherapy before repair. One patient had asymptomatic occlusion of the carotid stent.
IP067.
Outcomes of Surgeon-Modified Fenestrated Endografts in the Treatment of High-Risk and Acute Aortic Disease Objective: The application of surgeon-modified fenestrated endografts to high-risk and acute aortic disease is desirable because of the morbid nature of open repair; however, the feasibility of this is largely unknown. We sought to describe outcomes of surgeon-modified fenestrated endovascular aneurysm repair (sm-FEVAR) for acute and high-risk aortic disease in patients who were deemed poor surgical candidates.
Methods: We retrospectively queried institutional data for all patients treated with sm-FEVAR at our facility between 2009 and 2017. The sm-FEVAR was performed for clinical necessity, with the patient's consent, and in anticipation of a physician-sponsored investigational device exemption application (Q171179). Predictors of major complications were determined using either c 2 test or t-test. Survival, reinterventionfree survival, and branch patency were analyzed using the Kaplan-Meier methods.
Results: Thirty-seven patients (mean age, 72.0 6 8.0 years; 67.2% male; follow-up, 319 6 420 days) underwent sm-FEVAR for paravisceral aneurysm (n ¼ 13), thoracic aortic aneurysm (n ¼ 9), anastomotic pseudoaneurysm (n ¼ 7), type IA endoleak, status post EVAR (n ¼ 5), and chronic type B aortic dissection (n ¼ 3). Average maximum diameter was 67.5 6 21.0 mm. Fifteen patients (40.5%) were symptomatic; one patient was ruptured. There were 104 branches total (mean, 2.8 6 1.2; celiac, 22; superior mesenteric artery, 32; renal, 50). Major complications occurred in 32% of patients (30-day mortality, 10.8%; spinal cord ischemia, 18.9%; newonset dialysis, 8.1%; respiratory failure, 13.5%). Repair for thoracic aortic aneurysm was associated with spinal cord ischemia (odds ratio, 11.1; 95% confidence interval [CI], 1.49-82.4; P ¼ .01) and major complications (odds ratio, 5.54; 95% CI, 1.81-16.95; P < .01). One-year survival, reintervention-free survival, and branch patency were 88.6% (95% CI, 78.6%-99.8%), 59.0% (41.3%-84.3%), and 95.9% (90.3%-100%), respectively (Fig) . Endoleak was present in 39% of patients during follow-up.
Conclusions: In our early experience, perioperative morbidity for sm-FEVAR is significant; however, it is less than reported rates for open repair in such high-risk patients and can be used to treat a variety of aortic diseases. Further studies and experience are needed to improve perioperative outcomes, to reduce reinterventions, and to improve long-term durability.
Author Disclosures: W. Clouse: Nothing to disclose; M. F. Conrad: Nothing to disclose; C. DeCarlo: Nothing to disclose; R. Lancaster: Nothing to disclose; J. Mohebali: Nothing to disclose; V. I. Patel: Nothing to disclose. Methods: We performed a retrospective review of all patients who underwent FEVAR at our institution with the Zenith Fenestrated AAA Endovascular Graft (Cook Medical, Bloomington, Ind) from 2013 to 2018. Small, slow type I and type III endoleaks at the end of the index procedure were routinely observed. We identified patients with type I or type III endoleaks by review of the completion angiogram and subsequently characterized endoleak type and location.
Results: Of 49 patients who underwent FEVAR, 28 (57%) had evidence of a type I or type III endoleak after implantation of all devices. Eleven patients underwent further intervention at the index procedure, and three endoleaks resolved completely. Twenty-five patients (51%) had a type I or type III endoleak on completion angiography. We excluded three patients without postoperative imaging: two yet to complete initial postoperative computed tomography angiography or duplex ultrasound and one lost to follow-up after discharge. For the 22 remaining patients, mean age was 75.6 years; 77% were male, and 77% were white. Mean aneurysm diameter was 61 mm. There were 61 branch vessels (42 renal Type I (from large unstented right renal artery fenestration) 1 (5) a Exact location of endoleak origin could not be determined.
